Diagnosis and treatment of pleural mesothelioma. State of the art 2024

Zofia Lewandowska, Dariusz M. Kowalski

Online first

Review paper

Immunochemotherapy in patients with non-squamous lung cancer

Adam Płużański, Aleksandra Piórek

Online first

Review paper

Dual-organ toxicity during treatment with nivolumab and ipilimumab in combination with chemotherapy in the first-line treatment of non-small cell lung cancer

Agnieszka Dyzma-Kasprzak, Karol Kasprzak, Elżbieta Szczepaniak-Wójtowicz, Joanna Milanowska, Izabela Chmielewska, Paweł Krawczyk

Online first

Case report

Intramedullary spinal cord metastases in breast cancer discovered on fluorodeoxyglucose-positron emission tomography-computed tomography

Manale Otmani, Yassir Benameur, Omar Ait Sahel, Salah Oueriagli Nabih, Abderrahim Doudouh

Online first

Case report

Umbrella trials as a novel concept of cancer clinical trials — a systematic review

Mikołaj Bartoszkiewicz, Joanna Kufel-Grabowska, Paweł Burchardt

Online first

Review paper

Locally advanced thoracic NUT carcinoma — a case report and literature review

Piotr A. Chilczuk, Magdalena Knetki-Wróblewska

Online first

Case report

Melanoma of unknown origin with central nervous system metastases

Marta Pabianek, Magdalena Ciążyńska

Vol 20, Supp. A (2024)

Case report

Effectiveness of rechallenge with BRAF/ /MEK inhibitors in patient with advanced melanoma with BRAF V600 mutation

Katarzyna Woźniak

Vol 20, Supp. A (2024)

Case report

Efficacy of targeted therapies in the treatment of patients with melanoma harboring BRAF V600 mutation with central nervous system metastases

Monika Dudzisz-Śledź, Piotr Rutkowski

Vol 20, Supp. A (2024)

Review paper

A case of a patient treated with targeted therapy in brain metastases of melanoma with BRAF V600 mutation

Jan Żurawski

Vol 20, Supp. A (2024)

Case report

Response to encorafenib and binimetinib therapy after prior treatment with targeted therapy and immunotherapy in melanoma patient with brain metastases

Łukasz Galus

Vol 20, Supp. A (2024)

Case report

Encorafenib in combination with binimetinib in second line palliative treatment in 44-year patient with symptoms of spinal cord compression

Joanna Lompart

Vol 20, Supp. A (2024)

Case report

ERRATUM: Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer

Joanna Kufel-Grabowska

Vol 20, No 1 (2024)

Erratum

Treatment of advanced skin melanoma with BRAF V600 mutation with central nervous system metastases with encorafenib in combination with binimetinib

Natasza Kempa-Kamińska

Vol 20, Supp. A (2024)

Case report

Treatment with encorafenib and binimetinib of elderly female patient with BRAF-mutated melanoma with central nervous system metastases

Monika Dudzisz-Śledź

Vol 20, Supp. A (2024)

Case report

Introduction

Piotr Rutkowski

Vol 20, Supp. A (2024)

Other materials agreed with the Editors

Patient with M1d melanoma treated with encorafenib and binimetinib with partial response in the second line

Paulina Jagodzińska-Mucha

Vol 20, Supp. A (2024)

Case report